836例全血细胞减少患者临床特征分析

Abstract
Figure/Table
References (26)
Related Citation (3)

Download: PDF (577 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical characteristics of patients with pancytopenia in the third-class comprehensive hospital preliminarily. Methods A total of 836 patients with pancytopenia in our hospital from January 2016 to October 2020 were selected as the subjects, and divided into hemotopathy group (287 cases) and non-hemotopathy group (488 cases). The blood cell reduction degree were compared between the two groups. The distribution and cause of all patients were analyzed and summarized. Results Among the 836 patients, the degree of pancytopenia was mainly mild or moderate.There were 785 cases(93.9%)of mild and moderate anemia,Pations of platelet count([75-<125]×109/L)was 21 cases(62.32%),WBC count([2.0-<3.5]×109/L)was 763 cases(91.15%).Patients with pancytopenia were mainly distributed in Department of Haematology, Department of Emergency, Department of Respiratory Medicine, Department of General Surgery,Department of Gastroenterology,Department of Cardiology and other departments.According to the etiology, the 836 patients were divided into 287 cases (34.33%) of hemotopathy and 488 cases (58.37%) of non-hemotopathy.In hematopoietic system, megaloblastic anemia mainly accounted for 35.19%, followed by myelodysplastic syndrome(19.16%). In non-hematopoietic system, infection disease accounted for 34.06%, followed by metastatic tumor (18.5%).The decrease degree of leukocyte, hemoglobin and platelet in hemotopathy was higher than that in non-hemotopathy, the difference was statistically significant(P<0.05).Conclusion Clinicians of all specialties should pay attention to finding the etiology of pancytopenia,and improve the level of diagnosis and treatment. Pancytopenia is mainly caused by hematopoietic disorders, non-hematopoietic diseases also accounts for a certain percentage. Bone marrow cytology and laboratory tests should be actively performed to confirm the diagnosis and avoid missed diagnosis and misdiagnosis.

Key words： Pancytopenia Cause analysis Hemotopathy Non-hemotopathy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I8/42

[3]	陆跃武，耿华云.老年全血细胞减少症78 例临床分析[J].现代诊断与治疗，2012，23（8）：1183-1184.
[4]	蔡颖，曹永跃，马亮，等.222 例临床全血细胞减少患者的回顾性分析[J].国际检验医学杂志，2015，36（3）：319-321.
[5]	余娟娟，段小花，王秀华，等.成人全血细胞减少症413 例临床分析[J].中国卫生检验杂志，2017，27（15）：2205-2207.
[6]	陈秀明，莫晓冬.全血细胞减少的鉴别诊断[J].西藏医学，2017，38（6）：84-85.
[7]	王蕊，金芳，孟伟，等.全血细胞减少症中应用骨髓细胞学检查的可行性分析[J].中国临床医生杂志，2020，48（11）：1323-1325．
[1]	Vargas-Carretero CJ，Fernandez-Vargas OE，Ron-Magana AL，et al.Etiology and clinico-hematological profile of pancytopenia：experience of a Mexican Tertiary Care Center and review of the literature[J].Hematology，2019，24（1）：399-404.
[2]	US Department of Health and Human Services，National Institutes of Health （NIH）and National Cancer Institute（NCI）.Common terminology criteria for adverse events（CTCAE）version5.0[EB/OL].http://ctep.cancer gov/protocol Development/electronic_applications/ctc.htm.
[8]	马玉娟.114 例全血细胞减少患者的病因及血象分析[J]．临床医药文献杂志，2018，5（49）：45-47.
[9]	Kirk SE，Young E，Ray A，et al.Transient Pancytopenia Subsequently Diagnosed With Acute Leukemia：A Report of 4 Cases of Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia[J].J Pediatr Hematol Oncol，2021，45（3）：715-717．
[10]	赵小峰.45 例全血细胞减少患者的病因分析[J]．现代医学与健康研究，2019，3（10）：112-113.
[11]	李正发，杨同华，赵仁斌，等．Th17 细胞在免疫相关性全血细胞减少症中的免疫调节作用[J]．医学分子生物学杂志，2015，（1）：45-49.
[12]	邵宗鸿.骨髓衰竭性疾病研究进展[J].中华医学信息导报，2017，32（5）：21.
[13]	刘云川，孔瑞娟.多发性骨髓瘤误诊原因分析及防范措施[J].临床误诊误治，2020，33（11）：封3.
[14]	石雨薇，陈瑢，张宪军.全血细胞减少128 例骨髓及病因分析[J].中国老年学杂志，2013，33（24）：6287-6288.
[15]	祁森，杨昆鹏，付玥玥，等.345 例全血细胞减少骨髓检查与病因分析[J].哈尔滨医科大学学报，2016，50（1）：71-74.
[16]	蒋锐.全血细胞减少130 例病因分析[J].临床荟萃，2014，29（5）：565-566.
[17]	尤冬梅.全血细胞减少病因学探讨[J].国际检验医学杂志，2016，37（10）：1445-1446.
[18]	符火，林尤仕.失代偿期肝硬化患者全血细胞减少的临床病因与血象、骨髓象分析[J].中国卫生检验杂志，2016，26（1）：90-92，97.
[19]	白文英．慢性肾衰竭并发全血细胞减少[J].中国血液净化，2006，5（8）：463.
[20]	张春梅，滕清良，孙兆刚，等.全血细胞减少348 例临床分析[J].中国煤炭工业医学杂志，2005，8（8）：816-817.
[21]	张文权.全血细胞减少217 例临床分析[J].临床研究，2005，2（14）：44.
[22]	Yeo JH，Islam A.Renal failure and progressive pancytopenia[J].J R Coll Physicians Edinb，2018，48（4）：318-320.
[23]	胡慧仙.以全血细胞减少为首诊的原发性甲状腺功能减退症9 例临床分析[J].浙江医学，2001，23（12）：738-739.
[24]	刘真真，李冲，李婕一，等．Graves 病合并血液系统异常537 例临床分析[J]．郑州大学学报，2014，（2）：291-293.
[25]	史晓阳.颅咽管瘤术后全垂体功能减退症致全血细胞减少的临诊应对[J].中华内分泌代谢杂志，2019，35（10）：879-881.
[26]	雷荟融，刘尚勤.以全血细胞减少及顽固性低钠血症为表现的席汉综合征一例[J].临床内科杂志，2019，36（11）：1669-1670.